AU6916694A - Novel treatments for allergic diseases - Google Patents

Novel treatments for allergic diseases

Info

Publication number
AU6916694A
AU6916694A AU69166/94A AU6916694A AU6916694A AU 6916694 A AU6916694 A AU 6916694A AU 69166/94 A AU69166/94 A AU 69166/94A AU 6916694 A AU6916694 A AU 6916694A AU 6916694 A AU6916694 A AU 6916694A
Authority
AU
Australia
Prior art keywords
allergic diseases
novel treatments
treatments
novel
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69166/94A
Inventor
Jeff Alexander
Alessandra Franco
Howard M. Grey
Alessandro D Sette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytel Corp
Original Assignee
Cytel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytel Corp filed Critical Cytel Corp
Publication of AU6916694A publication Critical patent/AU6916694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU69166/94A 1993-05-19 1994-05-19 Novel treatments for allergic diseases Abandoned AU6916694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6429893A 1993-05-19 1993-05-19
US064298 1993-05-19
PCT/US1994/005632 WO1994026774A1 (en) 1993-05-19 1994-05-19 Novel treatments for allergic diseases

Publications (1)

Publication Number Publication Date
AU6916694A true AU6916694A (en) 1994-12-12

Family

ID=22054965

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69166/94A Abandoned AU6916694A (en) 1993-05-19 1994-05-19 Novel treatments for allergic diseases

Country Status (2)

Country Link
AU (1) AU6916694A (en)
WO (1) WO1994026774A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283899B1 (en) * 1996-01-26 1998-05-07 Ist Superiore Sanita PEPTIDES AND THEIR USES IN THE CELIAC DISEASE THERAPY
ES2126512B1 (en) * 1997-03-10 1999-12-01 Consejo Superior Investigacion SYNTHETIC PEPTIDE OF GAMMA-3 AVENINE FOR DIAGNOSIS AND MONITORING OF CELIAC DISEASE.
ES2527760T3 (en) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Treatment of Crohn's disease with copolymer 1 and polypeptides
WO2000005250A1 (en) 1998-07-23 2000-02-03 Yeda Research And Development Co., Ltd Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
JP2003521448A (en) 1998-07-23 2003-07-15 ザ・プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ Synthetic peptides and methods of use for treating autoimmune diseases
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
WO2000027417A1 (en) * 1998-11-12 2000-05-18 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating gvhd and hvgd
US7053043B1 (en) 1999-07-23 2006-05-30 Yeda Research And Development Co.Ltd. Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD
ZA200206457B (en) 2000-02-18 2003-08-13 Yeda Res & Dev Oral, nasal and pulmonary dosage formulations of copolymer 1.
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
CN1308683C (en) 2001-12-04 2007-04-04 特瓦制药工业有限公司 Process for the measurement of the potency of glatiramer acetate
US7320788B2 (en) 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US7303871B2 (en) 2002-02-14 2007-12-04 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7265093B2 (en) 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7462688B2 (en) 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
EP1507549A4 (en) 2002-05-14 2009-07-01 Univ Leland Stanford Junior Drug therapy for celiac sprue
ES2383595T3 (en) 2002-11-20 2012-06-22 The Board Of Trustees Of The Leland Stanford Junior University Celiac disease diagnostic procedure
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7534426B2 (en) 2004-04-26 2009-05-19 The Board Of Trustees Of The Leland Stanford Junior University Glutenase enzyme assays
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US7563864B2 (en) 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
WO2008115411A1 (en) 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
EP2391635B1 (en) 2009-01-28 2017-04-26 Epimmune Inc. Pan-dr binding polypeptides and uses thereof

Also Published As

Publication number Publication date
WO1994026774A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
AU6916694A (en) Novel treatments for allergic diseases
AU7867994A (en) Hemofiltration of mediator-related diseases
AU6623894A (en) Therapeutic compounds
AU696805B2 (en) Soft tissue
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
AU7516194A (en) Wound treatment
AU1248395A (en) Bandages
AU1173195A (en) Treatment of immunoregulatory disorders
AU6801694A (en) The treatment of small animals
AU5866894A (en) Wheelchair
AU6092794A (en) Oxime-substituted therapeutic compounds
AU6010594A (en) Isoxazoleoxy derivative
AU6388494A (en) Skin care composition
AU3263493A (en) Tonometer
AU6337294A (en) Ophthalmic topical agent
AU6723294A (en) Use of simmondsine
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU5737494A (en) Human thrombospondin-4
AU1249395A (en) Topical treatment of ocular photophobia
AUPM307793A0 (en) Prophylaxis of allergic disease
AU6511294A (en) Tonometer
AU6256994A (en) P-dinitroso benzole
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU671899B2 (en) 5-O-desosaminylerythronolide derivative
AU8110494A (en) Bandages